Proteus Infections - 11 Studies Found
Enrolling by invitation |
: Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome : Proteus Syndrome : 2015-10-31 : Drug: ARQ 092 |
Recruiting |
: Study of Proteus Syndrome and Related Congenital Disorders :
|
Withdrawn |
: Proteus Sustained Behavior Change Study : Type 2 Diabetes Mellitus : 2011-12-28 :
|
Completed |
: Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes :
|
Recruiting |
: Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies :
: 2017-03-17 : Drug: ARQ 092 Subjects will receive ARQ 092 orally at the dose level and administration schedule specifi |
Completed |
: Community - Associated Extended-spectrum Beta-lactamases (ESBL) :
|
Active, not recruiting |
: Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. : High Risk Proliferative Diabetic Retinopathy : 2013-09-10 :
|
Completed |
: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants :
: 2011-03-21 : Drug: ECMPS-IEM ECMPS-IEM |